Physician profile
Daniel R Wright
NPI 1437535267
$2,973.63
in general payments reported to CMS, 2019-2025
15 companies · $807 in 2025
The $807 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.47 · 2020: $97.28 · 2021: $199 · 2022: $1,656 · 2023: $74.71 · 2024: $66.74 · 2025: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $948.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,632.97 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $370.01 | 2021-2025 | Nuzyra, Xhance |
| Averitas Pharma INC. | $316.45 | 2023-2025 | Qutenza |
| Flower Orthopedics Coporation | $200.33 | 2021-2022 | |
| Trilliant Surgical LLC. | $97.28 | 2020 | |
| Organogenesis INC. | $74.11 | 2022-2023 | Puraply |
| Stryker Corporation | $63.69 | 2025 | Augment Injectable |
| Smith+Nephew, INC. | $46.91 | 2022-2025 | Collagenase Santyl |
| Bioventus LLC | $37.72 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $35.94 | 2019 | |
| Nevro Corp. | $26.93 | 2021 | |
| In2bones USA, LLC | $25.82 | 2019 | |
| Kerecis Limited | $16.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $16.86 | 2024 | V.A.C.Ulta |
| Orthofix Medical, INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.